Plain-English translation of NCT06439277 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing , a medication given as a weekly injection, to see if it can help teenagers with obesity lose weight and improve related health conditions. The study will compare this medication to a placebo (a dummy injection) to understand how well it works and whether it's safe for young people. About 300 teenagers will participate.
Many teenagers struggle with obesity and related health problems like high blood pressure and prediabetes, but there are limited treatment options designed specifically for this age group. This trial is exploring whether this medication could become a safe and effective tool to help teenagers manage their weight and improve their overall health.
You likely qualify if…
You likely don't qualify if…
If you qualify, you'll be randomly assigned to receive either the study medication or a placebo injection once per week. You'll visit the clinic regularly so doctors can check how you're doing, monitor your weight and health markers, and watch for any side effects. The study will track your progress over several months to see if the medication helps you lose weight and improve your related health conditions.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
United States